¿¬¼ö°­ÁÂ
°­³²¼¼ºê¶õ½ºº´¿ø ´ëÇѺ´¸®ÇÐȸ ½ÅÀ庴¸®¿öÅ©¼¥ : 2019-09-21
°­³²¼¼ºê¶õ½ºº´¿ø ´ëÇѺ´¸®ÇÐȸ ½ÅÀ庴¸®¿öÅ©¼¥ : 2019-09-21
±³À°ÀÏÀÚ : 2019-09-21
±³À°Àå¼Ò : °­³²¼¼ºê¶õ½ºº´¿ø º»°ü ´ë°­´ç  
±³À°ÁÖÁ¦ : ½ÅÀ庴¸®¿öÅ©¼¥
ÁÖÃÖ±â°ü : ´ëÇѺ´¸®ÇÐȸ
´ã´çÀÚ : ´ëÇѺ´¸®ÇÐȸ
¿¬¶ôó : 02-795-3094  
À̸ÞÀÏ : kspjamoon@kams.or.kr      
±³À°Á¾·ù : º´¸®°ú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 5ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í »çÀüµî·Ï Àü°øÀÇ 5¸¸¿ø, Àü¹®ÀÇ 7¸¸¿ø ÇöÀåµî·Ï Àü°øÀÇ 6¸¸¿ø, Àü¹®ÀÇ 8¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-21 º»°ü ´ë°­´ç 10:05~10:35 Glomerulonephritis with organized deposit  ¼º¼øÈñ(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 09-21 º»°ü ´ë°­´ç 10:35~11:05 Renal diseases associated with monoclonal immunoglobulins other than amyloidosis  ÇÑÁö¿µ(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 09-21 º»°ü ´ë°­´ç 11:20~11:50 Diabetic nephropathy  ¾ö¹Î¼·(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 09-21 º»°ü ´ë°­´ç 11:50~12:20 Lupus nephritis and other connective tissue diseases  ±è¹Ì¼º(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-21 º»°ü ´ë°­´ç 13:30~14:15 aHUS and thrombotic microangiopathy  ¹®°æö,ÀÌÇÏÁ¤(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-21 º»°ü ´ë°­´ç 14:15~14:55 Clinical aspects of renal allograft dysfunction  Á¤º´ÇÏ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-21 º»°ü ´ë°­´ç 15:10~15:40 Diagnosis of allograft rejection: review  ÀÓ¹üÁø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-21 º»°ü ´ë°­´ç 15:40~16:20 Banff classification: recent update  ±Ç±â¿µ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-21 º»°ü ´ë°­´ç 16:20~16:50 BK virus nephropathy and other complications of allograft kidney  ÇѸ¸ÈÆ(°æºÏÀÇ´ë) 
  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­Á : 2024-03-09

±³À°ÀÏÀÚ : 2024-03-09 ±³À°Àå¼Ò : (¿Â¶óÀÎ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å¼ººóÇ÷¿¬

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,657 , ´ñ±Û¼ö : 0

[¼­¿ï] Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialysis Vascular Access) : 2024-03-31

±³À°ÀÏÀÚ : 2024-03-31 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ ±³À°ÁÖÁ¦ : Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialy

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,712 , ´ñ±Û¼ö : 0

[ºÎ»ê] 2024 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸ : 2024-03-16

±³À°ÀÏÀÚ : 2024-03-16 ±³À°Àå¼Ò : ÇØ¿î´ë¹éº´¿ø 5Ãþ ´ë°­´ç ±³À°ÁÖÁ¦ : 2024 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÄ¡¸ÅÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ºÎ»ê¿ï

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,708 , ´ñ±Û¼ö : 0

[¼­¿ï] ¼¼ºê¶õ½ºº´¿ø 2018 ¼¼¸ñȸ Çмú´ëȸ : 2018-11-10

±³À°ÀÏÀÚ : 2018-11-10 ±³À°Àå¼Ò : °­³² ¼¼ºê¶õ½ºº´¿ø ´ë°­´ç ±³À°ÁÖÁ¦ : 2018 ¼¼¸ñȸ Çмú´ëȸ ÁÖÃÖ±â°ü : ¼¼ºê¶õ½ºº´¿ø ½ÃÇà±â°ü(ÁöºÎ/°ú) : ¾È°ú ´ã´çÀÚ : ¹Ú

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,392 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÁ¶Çöº´ÇÐȸ Treatment and management of symptoms and physical health in schizophrenia : 2024-04-2..

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ±³À°ÁÖÁ¦ : Treatment and management of symptoms and physical health i

Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,398 , ´ñ±Û¼ö : 0